This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Lupin, Inc.. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2019
Title: Innovations by Inamus Saqlain Ansari: Pioneering Patents in Pharmaceuticals
Introduction
Inamus Saqlain Ansari, a talented inventor based in Pune, India, has made significant contributions to the pharmaceutical field through his innovative work. With two patents to his name, his research focuses on the process improvements related to important pharmaceutical compounds.
Latest Patents
Inamus Saqlain Ansari's latest patents include groundbreaking advancements in the preparation of vortioxetine and the synthesis of a 1,4-diphenylazetidinone. The first patent details a process for the isolation of an intermediate of vortioxetine in a solid-state form, presenting an improved, commercially viable, and industrially advantageous method for preparing vortioxetine or a pharmaceutically acceptable salt, achieving high yield and purity. The second patent describes a method for synthesizing a 1,4-diphenylazetidinone using novel oxime intermediates, showcasing his innovative approach to pharmaceuticals.
Career Highlights
Inamus is currently associated with Lupin, Inc., where he contributes to the development of new pharmaceutical processes and products. His expertise in chemical processes and patentable innovations highlights his role in advancing pharmaceutical technologies.
Collaborations
Throughout his career, Inamus has worked alongside talented colleagues such as Girij Pal Singh and Dhananjai Srivastava. These collaborations have further enriched the innovative environment at Lupin, Inc., driving forward both research and patent applications in the pharmaceutical sector.
Conclusion
Inamus Saqlain Ansari stands out as a promising inventor whose patents demonstrate a commitment to advancing pharmaceutical development. His work not only enhances the efficiency of drug preparation but also contributes significantly to the field of pharmaceutical sciences. With a focus on innovation and collaboration, Inamus continues to pave the way for future breakthroughs in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
